10 tips for non-pharmacological interventions with the potential to modify fracture risk in CKD patients are described, which are often applicable to patients with CKD without restrictions, with some specific considerations in end-stage kidney disease.
Abstract
ABSTRACT Chronic kidney disease (CKD)-associated osteoporosis is present in approximately 25% of all patients with CKD. The occurrence increases as kidney function declines, with prevalences up to 75% in elderly dialysis patients. It is often undiagnosed due to the perception that limited treatment options are available for this condition. This inappropriate assumption leads to diagnostic and therapeutic nihilism. The effect-size of pharmacological interventions on bone mineral density in patients with CKD is comparable to or higher than in other forms of osteoporosis. Non-pharmacological interventions can improve bone strength and fracture risk in addition to pharmacological interventions. Importantly, they are often applicable to patients with CKD without restrictions, with some specific considerations in end-stage kidney disease. Due to the increased prevalence of modifiable risk factors for fragility fractures in CKD, non-pharmacological interventions should be provided to all patients with CKD-associated osteoporosis. We review the current literature and describe 10 tips for non-pharmacological interventions with the potential to modify fracture risk in CKD patients: appropriate intake of calcium and vitamin D, adequate nutrition and protein intake, avoidance of smoking and alcohol, medication review, reinforcement of exercise, reducing risk of home hazards, prevention of orthostatic hypotension, taking care of neuropathy and determining fall risk, as well as implementing fracture liaison services, are all actions of relevance to the patient with CKD-associated osteoporosis. As in the general population, non-pharmacological interventions should be the first option to consider when osteoporosis is diagnosed. With this paper, we suggest how this should be tailored to the patient with CKD.
BACKGROUND
Osteoporosis and fragility fractures are major causes of disability, loss of independence, institutionalization, and mortality in the oldest old. Despite their exceptionally high fracture risk, adults aged ≥80 years remain underrepresented in randomized controlled trials. Diagnosis and treatment are complica...
H. Dimai, B. Obermayer-Pietsch· Gerontology· 0 citations
DEXA-based bone mineral density evaluation enhances clinical risk stratification, promotes the initiation of evidence-based pharmacologic therapy, and improves osteoporosis detection, and the use of DEXA within FLS models improved treatment adherence and subsequently reduced the number of secondary fractures.
Gabrielle Bartolovic, Isabella Aperfine, E. Cunningham et al.· Journal of orthopedics for p...· 0 citations
Chronic kidney disease (CKD) is among the most prevalent non-communicable diseases globally and is recognized as a significant independent risk factor for cardiovascular complications (CVCs). The co-occurrence of overweight or obesity in patients with CKD exacerbates its role as a risk factor for CVCs. Objective. To ev...
I. Murkamilov, K. Aitbaev, V. V. Fomin et al.· Russian Journal of Preventiv...· 0 citations
Key recommendations include the need for routine frailty screening using multi-dimensional tools, a frailty-informed, person-centred framework for shared decision-making that emphasizes transparent communication, goal elicitation and cultural safety, and flexible KRT delivery guided by serial frailty measurement.
P. Li, G. Chan, M. McAdams-DeMarco et al.· Nature Reviews Nephrology· 1 citation
Frailty fractures in the elderly represent an important public health problem, associated with population aging, osteoporosis, and increased risk of falls. These injuries can significantly compromise mobility, autonomy, and quality of life, in addition to favoring hospitalizations, clinical complications, and functiona...
M. A. F. Cançado, Flávio Salles Previti, Matheus de Sousa Albuquerque· International Health Science...· 0 citations
Type 2 diabetes mellitus (T2DM) and osteoporosis are both common age-related metabolic diseases, and their coexistence significantly increases the fracture risk of patients. Patients with T2DM often present with normal or even increased bone mineral density, yet exhibit a higher incidence of fractures, making it diffic...
Xiu-Ling Shen, Bo Zhou· The Journal of Bioscience an...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.